The psychological burden during COVID-19 pandemic in a cohort of patients affected by moderate-to-severe atopic dermatitis treated with dupilumab

被引：0
|
作者：
Quattrini, Laura [1 ,2 ]
Chiricozzi, Andrea [1 ,2 ]
Gori, Niccolo [2 ]
Di Nardo, Lucia [2 ]
D'Urso, Dario F. [1 ,2 ]
Malvaso, Dalma [1 ,2 ]
Cornacchia, Luigi [1 ,2 ]
Pano, Silvia Cata [1 ,2 ]
Peris, Ketty [1 ,2 ]
机构：
[1] IRCCS A Gemelli Univ Polyclin Fdn, Unit Dermatol, Dept Med & Surg Sci, Largo Francesco Vito 1, I-00168 Rome, Italy
[2] Sacred Heart Catholic Univ, Unit Dermatol, Univ Dept Translat Med & Surg, Largo Francesco Vito 1, I-00168 Rome, Italy
来源：
ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY | 2023年 / 158卷 / 04期
关键词：
D O I：
10.23736/S2784-8671.23.07475-3
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：365 / 367
页数：4
相关论文
共 50 条
  • [1] COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab
    Ungar, Benjamin
    Glickman, Jacob W.
    Golant, Alexandra K.
    Dubin, Celina
    Marushchak, Olga
    Gontzes, Alyssa
    Mikhaylov, Daniela
    Singer, Giselle K.
    Baum, Danielle
    Wei, Nancy
    Sanin, Antonio
    Gruenstein, Diana
    Lebwohl, Mark G.
    Pavel, Ana B.
    Guttman-Yassky, Emma
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (01): : 134 - 142
  • [2] Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitis
    Marcant, P.
    Balaye, P.
    Merhi, R.
    Jendoubi, F.
    Nosbaum, A.
    Raison-Peyron, N.
    Du-Thanh, A.
    Lasek, A.
    Ferrier le Bouedec, M. -C.
    Tetart, F.
    Valois, A.
    Barbarot, S.
    Soria, A.
    Jachiet, M.
    Staumont-Salle, D.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (06) : E394 - E396
  • [3] Clinically meaningful responses in moderate-to-severe atopic dermatitis patients treated with Dupilumab
    de Bruin-Weller, M.
    Eckert, L.
    Simpson, E. L.
    Cork, M. J.
    Ardeleanu, M.
    Chen, Z.
    Shumel, B.
    Rossi, A. B.
    Graham, N. M. H.
    Pirozzi, G.
    Gadkari, A.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 116 - 116
  • [4] COVID-19 Does Not Influence the Time to Relapse Following Dupilumab Discontinuation in Patients With Moderate-to-Severe Atopic Dermatitis
    Sun, Xiu-Kun
    [J]. DERMATITIS, 2024, 35 (05) : 523 - 524
  • [5] Facial dermatoses and use of protective mask during Covid-19 pandemic: A clinical and psychological evaluation in patients affected by moderate-severe atopic dermatitis under treatment with dupilumab
    Vanessa, Mazzoletti
    Elia, Esposto
    Federica, Veronese
    Edoardo, Cammarata
    Chiara, Airoldi
    Francesca, Graziola
    Paola, Savoia
    [J]. DERMATOLOGIC THERAPY, 2022, 35 (07)
  • [6] Dupilumab in the treatment of moderate-to-severe atopic dermatitis
    Kraft, Magdalena
    Worm, Margitta
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (04) : 301 - 310
  • [7] Dupilumab: A Review in Moderate-to-Severe Atopic Dermatitis
    Frampton, James E.
    Blair, Hannah A.
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2018, 19 (04) : 617 - 624
  • [8] Dupilumab: A Review in Moderate-to-Severe Atopic Dermatitis
    James E. Frampton
    Hannah A. Blair
    [J]. American Journal of Clinical Dermatology, 2018, 19 : 617 - 624
  • [9] Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients
    Achten, Roselie
    Thijs, Judith
    van Luijk, Chantal
    Knol, Edward
    Delemarre, Eveline
    de Graaf, Marlies
    Bakker, Daphne
    de Boer, Joke
    van Wijk, Femke
    de Bruin-Weller, Marjolein
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (02): : 239 - 243
  • [10] Symptom burden of patients with moderate-to-severe atopic dermatitis
    Alexander Egeberg
    Peter Anderson
    James Piercy
    Lucy Massey
    Joseph C. Cappelleri
    Gerardo A. Encinas
    Claire Feeney
    Marco Dibonaventura
    [J]. European Journal of Dermatology, 2021, 31 : 752 - 758
12345